News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
707,700 Results
Type
Article (43371)
Company Profile (275)
Press Release (664054)
Multimedia
Podcasts (53)
Webinars (12)
Section
Business (205554)
Career Advice (2029)
Deals (35562)
Drug Delivery (97)
Drug Development (81664)
Employer Resources (173)
FDA (16289)
Job Trends (14965)
News (347470)
Policy (32802)
Tag
Academia (2636)
Accelerated approval (6)
Adcomms (23)
Allergies (87)
Alliances (49932)
ALS (96)
Alzheimer's disease (1390)
Antibody-drug conjugate (ADC) (134)
Approvals (16277)
Artificial intelligence (265)
Autoimmune disease (22)
Automation (16)
Bankruptcy (363)
Best Places to Work (11727)
BIOSECURE Act (20)
Biosimilars (106)
Biotechnology (200)
Bladder cancer (79)
Brain cancer (28)
Breast cancer (292)
Cancer (2326)
Cardiovascular disease (180)
Career advice (1693)
Career pathing (30)
CAR-T (156)
Cell therapy (442)
Cervical cancer (20)
Clinical research (66453)
Collaboration (866)
Company closure (2)
Compensation (560)
Complete response letters (21)
COVID-19 (2629)
CRISPR (44)
C-suite (254)
Cystic fibrosis (102)
Data (2310)
Decentralized trials (2)
Denatured (19)
Depression (45)
Diabetes (275)
Diagnostics (6450)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (123)
Drug pricing (104)
Drug shortages (25)
Duchenne muscular dystrophy (97)
Earnings (87276)
Editorial (39)
Employer branding (21)
Employer resources (147)
Events (113561)
Executive appointments (742)
FDA (17658)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (771)
Gene editing (115)
Generative AI (21)
Gene therapy (326)
GLP-1 (724)
Government (4462)
Grass and pollen (5)
Guidances (150)
Healthcare (18948)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (123)
Indications (29)
Infectious disease (2774)
Inflammatory bowel disease (144)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (97)
Interviews (318)
IPO (16586)
IRA (40)
Job creations (3658)
Job search strategy (1437)
Kidney cancer (10)
Labor market (43)
Layoffs (483)
Leadership (17)
Legal (7967)
Liver cancer (78)
Lung cancer (328)
Lymphoma (157)
Machine learning (9)
Management (58)
Manufacturing (322)
MASH (74)
Medical device (13402)
Medtech (13407)
Mergers & acquisitions (19541)
Metabolic disorders (707)
Multiple sclerosis (82)
NASH (16)
Neurodegenerative disease (93)
Neuropsychiatric disorders (28)
Neuroscience (1944)
NextGen: Class of 2025 (6584)
Non-profit (4548)
Now hiring (40)
Obesity (374)
Opinion (210)
Ovarian cancer (80)
Pain (93)
Pancreatic cancer (89)
Parkinson's disease (150)
Partnered (21)
Patents (243)
Patient recruitment (115)
Peanut (46)
People (57777)
Pharmaceutical (63)
Pharmacy benefit managers (19)
Phase I (20759)
Phase II (29257)
Phase III (21775)
Pipeline (1347)
Policy (147)
Postmarket research (2584)
Preclinical (8879)
Press Release (67)
Prostate cancer (107)
Psychedelics (31)
Radiopharmaceuticals (247)
Rare diseases (399)
Real estate (5949)
Recruiting (65)
Regulatory (22513)
Reports (47)
Research institute (2422)
Resumes & cover letters (354)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (71)
Series A (134)
Series B (88)
Service/supplier (12)
Sickle cell disease (55)
Special edition (17)
Spinal muscular atrophy (158)
Sponsored (29)
Startups (3633)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (49)
The Weekly (32)
Vaccines (710)
Venture capitalists (42)
Weight loss (238)
Women's health (36)
Worklife (16)
Date
Last 7 days (933)
Last 30 days (2963)
Last 365 days (32577)
2025 (11745)
2024 (35485)
2023 (40328)
2022 (51535)
2021 (56046)
2020 (54405)
2019 (46880)
2018 (35319)
2017 (32459)
2016 (31930)
2015 (37930)
2014 (31655)
2013 (26843)
2012 (29023)
2011 (29673)
2010 (27747)
Location
Africa (743)
Alabama (54)
Alaska (7)
Arizona (234)
Arkansas (13)
Asia (38382)
Australia (6315)
California (6408)
Canada (2062)
China (533)
Colorado (271)
Connecticut (284)
Delaware (156)
Europe (83015)
Florida (948)
Georgia (212)
Idaho (57)
Illinois (546)
India (25)
Indiana (319)
Iowa (11)
Japan (171)
Kansas (106)
Kentucky (25)
Louisiana (11)
Maine (62)
Maryland (922)
Massachusetts (4775)
Michigan (224)
Minnesota (401)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (67)
New Hampshire (64)
New Jersey (1787)
New Mexico (28)
New York (1805)
North Carolina (1001)
North Dakota (8)
Northern California (2814)
Ohio (209)
Oklahoma (14)
Oregon (34)
Pennsylvania (1428)
Puerto Rico (13)
Rhode Island (33)
South America (1119)
South Carolina (25)
South Dakota (1)
Southern California (2409)
Tennessee (105)
Texas (948)
United States (24015)
Utah (188)
Virginia (151)
Washington D.C. (64)
Washington State (575)
West Virginia (3)
Wisconsin (57)
707,700 Results for "myriad genetics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Myriad Genetics Announces RiskScore Study Published in JCO Precision Oncology
May 8, 2025
·
4 min read
Press Releases
Myriad Genetics to Release First Quarter 2025 Financial Results on May 6, 2025
April 30, 2025
·
1 min read
Press Releases
Myriad Genetics Reports First Quarter 2025 Financial Results; Updates 2025 Financial Guidance
May 7, 2025
·
28 min read
Press Releases
Myriad Genetics Names Brian Donnelly as New Chief Commercial Officer
April 8, 2025
·
3 min read
Press Releases
Myriad Genetics Announces Senior Leadership Transition
February 25, 2025
·
4 min read
Press Releases
Myriad Genetics Highlights MRD Clinical Validity Data at American Association for Cancer Research Annual Meeting
April 25, 2025
·
6 min read
Press Releases
Myriad Genetics and Gabbi to Work Together to Increase Access to Hereditary Cancer Risk Assessment Tools
February 28, 2025
·
3 min read
Press Releases
Myriad Genetics Announces Study Results Show Patients with Depression had Fewer Psychiatric Hospitalizations after GeneSight Testing
April 22, 2025
·
5 min read
Press Releases
Myriad Genetics Introduces Online Prenatal Genetic Testing Resource
January 23, 2025
·
4 min read
Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool
Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that Genetics in Medicine, an official journal of the American College of Medical Genetics and Genomics (ACMG), published a new study validating RiskScore®, Myriad’s breast cancer risk assessment tool integrated into its MyRisk® Hereditary Cancer Test.
June 3, 2024
·
4 min read
1 of 70,770
Next
